Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: Report of two cases

Diseases of the Colon and Rectum

Volumn 41, Issue 1, 1998, Pages 98-102

  Van Dullemen, Hendrik M ^a,b   De Jong, Ella ^a   Slors, Frederik ^a   Tytgat, Guido N J ^a   Van Deventer, Sander J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti tumor necrosis factor chimeric monoclonal antibody; Crohn's disease; Metastatic; Perineal wound; Proctectomy; Tumor necrosis factor

Indexed keywords

CHIMERIC ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CA 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; CROHN DISEASE; FEMALE; HUMAN; HYPOTHESIS; INFLAMMATORY CELL; METASTASIS; RECTUM RESECTION; WOUND HEALING;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; C-REACTIVE PROTEIN; CROHN DISEASE; FEMALE; HUMANS; PERINEUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031963180     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236903     Document Type: Article

References (16)

1. Marks CG, Ritchie JK, Todd IP, Wadsworth J. Primary suture of the perineal wound following rectal excision for inflammatory bowel disease. Br J Surg 1978;65: 560-4.
2. Williams N, Scott NA, Watson JS, Irving MH. Surgical management of perineal and metastatic cutaneous Crohn's disease. Br J Surg 1993;80:1596-8.
3. Keighley MR, Allan RN. Current status and influence of operation on perianal Crohn's disease. Int J Colorectal Dis 1986;1:104-7.
4. Scammell B, Keighley MR. Delayed perineal wound healing after proctocolectomy for Crohn's disease. Br J Surg 1986;73:150-2.
5. Brady CE, Cooley BJ, Davis JC. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygen. Gastroenterology 1989;97:756-60.
6. Potter WA, Bicks RO. The effects of hyperbaric oxygen therapy on the perineal/perivaginal fistulas of Crohn's disease with hyperbaric oxygen [abstract]. Gastroenterology 1991;100:A241.
7. Kinder V, Sappino AP, Grau G, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bacterial granulomas during BCG infection. Cell 1989;56:731-40.
8. Lukacs NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL. Inflammatory granuloma formation is mediated by TNF-α-inducible intercellular adhesion molecule-1. J Immunol 1994;152:5883-9.
9. Flory CM, Jones ML, Miller BF, Warren JS. Regulatory roles of tumor necrosis factor-alpha and interleukin-1 beta in monocyte chemoattractant protein-1-mediated pulmonary granulomaformation in the rat. Am J Pathol 1995;146:450-62.
10. van Dullemen HM, Deventer SJ, Hommes DW, Bijl HA, Tytgat GN, Woody J. Treatment of severe Crohn's disease with an anti-tumor necrosis factor chimeric monoclonal antibody. Gastroenterology 1995;109:129-35.
11. Kafity AA, Pelligrini AE, Fromkes JJ. Metastatic Crohn's disease: a rare cutaneous manifestation. J Clin Gastroenterol 1993;17:300-3.
12. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
13. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL. Cytokine function during mycobacterial and schistosomal antigen-induced pulmo-nary granuloma formation: local and regional participation of IFN-gamma, IL-10, and TNF. J Immunol 1995;54:5969-76.
14. Elliot MJ, Maini RN, Feldman M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor 181 (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
15. Elliott MJ, Maini RN, Feldman M, et al. Repeated therapy with monoclonal antibody to tumour necrosis factor 181 (cA2) in patients with rheumatoid arthritis. Lancet 1994;344:1125-7.
16. Elliott MJ, Maini RN, Feldman M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor 181. Arthritis Rheum 1993; 36:1681-90.